VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 26 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,294 | +7.4% | 34,440 | 0.0% | 0.00% | – |
| Q4 2022 | $4,000 | -33.3% | 34,440 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -83.3% | 34,440 | -15.4% | 0.00% | – |
| Q2 2022 | $36,000 | -12.2% | 40,709 | +24.1% | 0.00% | – |
| Q1 2022 | $41,000 | -50.6% | 32,809 | -23.2% | 0.00% | – |
| Q4 2021 | $83,000 | +2.5% | 42,696 | +45.0% | 0.00% | – |
| Q3 2021 | $81,000 | +84.1% | 29,441 | +110.7% | 0.00% | – |
| Q2 2021 | $44,000 | -87.9% | 13,971 | -91.8% | 0.00% | -100.0% |
| Q1 2021 | $365,000 | +9.6% | 171,414 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $333,000 | +179.8% | 171,414 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | +32.2% | 171,414 | 0.0% | 0.00% | – |
| Q2 2020 | $90,000 | +20.0% | 171,414 | 0.0% | 0.00% | – |
| Q1 2020 | $75,000 | – | 171,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 20,000 | $14,000 | 0.02% |
| Hartford Financial Management Inc. | 16,000 | $11,000 | 0.00% |
| RBF Capital, LLC | 25,000 | $19,000 | 0.00% |
| Koshinski Asset Management, Inc. | 20,000 | $14,000 | 0.00% |
| Financial Advocates Investment Management | 23,097 | $16,000 | 0.00% |
| D.A. DAVIDSON & CO. | 110,000 | $76,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 162,714 | $112,000 | 0.00% |
| HighTower Advisors, LLC | 132,328 | $91,000 | 0.00% |
| Virtu Financial LLC | 15,854 | $11,000 | 0.00% |
| BlackRock Inc. | 31,631 | $22,000 | 0.00% |